Interferon-alpha modulates the immune response enhancing B7-1 and B7-2 costimulatory molecules and T8 lymphocytes in chronic myeloid leukemia.
Delfini
C
C
Centis
F
F
Tabellini
L
L
Nicolini
G
G
Visani
G
G
D017951:Antigen Presentation; D015703:Antigens, CD / Q000032:analysis / Q000378:metabolism*; D018122:B7-1 Antigen / Q000378:metabolism*; D051940:B7-2 Antigen; D018414:CD8-Positive T-Lymphocytes / Q000378:metabolism*; D003713:Dendritic Cells / Q000187:drug effects; D015973:Gene Expression Regulation, Leukemic / Q000187:drug effects; D006801:Humans; D007111:Immunity, Cellular; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000494:pharmacology*; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy / Q000378:metabolism*; D008562:Membrane Glycoproteins / Q000378:metabolism*; D011994:Recombinant Proteins
D015703:Antigens, CD; D018122:B7-1 Antigen; D051940:B7-2 Antigen; C497964:CD86 protein, human; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D008562:Membrane Glycoproteins; D011994:Recombinant Proteins